Sartorius AG (STU:SRT)
€ 188.6 3.2 (1.73%) Market Cap: 14.82 Bil Enterprise Value: 18.74 Bil PE Ratio: 64.45 PB Ratio: 4.97 GF Score: 91/100

Q4 2021 Sartorius AG Earnings Call Transcript

Jan 27, 2022 / 02:30PM GMT
Release Date Price: €387 (-0.13%)
Operator

Good day, and welcome to the Sartorius and Sartorius Stedim Biotech Conference Call on the Preliminary Fiscal Year 2021 Results. Today's conference is being recorded.

At this time, I would like to turn the conference over to Dr. Joachim Kreuzburg, CEO. Please go ahead, sir.

Joachim Kreuzburg
Sartorius Aktiengesellschaft - Chairman of Executive Board & CEO

Thank you very much, and welcome, everybody, to our conference call today on the preliminary numbers for fiscal year 2021 for both the Sartorius Group as well as for Sartorius Stedim Biotech. As always, I will run this call together with our CFO, Rainer Lehmann, who will walk you through the details of our financial results in a minute.

Before that, I would like to start off by talking a little bit about maybe the highlights and the most important results of last year. I think it's fair to say that 2021 has been an outstanding year for both divisions, very strong growth rates that we have achieved in both divisions, both top line as well as bottom line. We also were able to further

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot